Pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, as well as other inflammatory mediators like PGE2, play a role in cancer pain across various cancer types.438,439 Therapies targeting pro-inflammatory molecules are becoming potential solutions for managing pain. This evidence concerns the gene IL1B and cancer.